Crossvault Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$3.45M |
| 2 |
PepsiCo
PEP
|
+$2.03M |
| 3 |
Dominion Energy
D
|
+$1.24M |
| 4 |
Salesforce
CRM
|
+$926K |
| 5 |
Lockheed Martin
LMT
|
+$909K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.58M |
| 2 |
X
US Steel
X
|
+$2.3M |
| 3 |
RTX Corp
RTX
|
+$1.5M |
| 4 |
Gilead Sciences
GILD
|
+$509K |
| 5 |
Netflix
NFLX
|
+$436K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 20.05% |
| 2 | Technology | 16.7% |
| 3 | Healthcare | 15.39% |
| 4 | Consumer Discretionary | 12.72% |
| 5 | Financials | 11.88% |
Similar funds
Crossvault Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, Crossvault Capital Management held 81 positions worth $176M, down 9.2% from $194M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Crossvault Capital Management deployed $12.3M of net new capital in Q4 2018, opening 17 new positions and adding to 30 existing holdings. Its largest new stake was Intuitive Surgical: 20,370 shares worth $3.25M.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 22% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was RTX Corp, an estimated $1.5M trimmed.
- Crossvault Capital Management's largest Q4 2018 buy was Intuitive Surgical: 20,370 shares worth $3.25M.
- Crossvault Capital Management added most to PepsiCo in Q4 2018, an estimated $2.03M increase.
- Crossvault Capital Management's biggest Q4 2018 reduction was RTX Corp, cutting an estimated $1.5M.
- Crossvault Capital Management fully exited SLB Ltd in Q4 2018, selling an estimated $2.58M.
- Crossvault Capital Management's ten largest holdings make up 43% of its $176M portfolio in Q4 2018.
- Crossvault Capital Management opened 17 new positions and closed 5 in Q4 2018.
- Crossvault Capital Management's portfolio value fell 9.2% quarter-over-quarter to $176M.
Based on Crossvault Capital Management's 13F filing for Q4 2018, filed 30 Jan 2019.